Medinotec FY27 Q1 net income rises to USD 222,014; revenue increases 24% to USD 2.65 million

MEDINOTEC INC

MEDINOTEC INC

MDNC

0.00

  • Medinotec posted net income of USD 222,014 for the quarter ended May 31, 2026, up USD 108,230 year over year.
  • Revenue rose 24% to USD 2.65 million, while gross margin widened 6 percentage points to 49%.
  • Operating income slipped to USD 180,872 from USD 277,457, as operating expenses climbed 77% to USD 1.13 million.
  • Selling expenses increased to USD 503,255 from USD 21,773, driven by distributor support costs tied to South African cardiology and renal dialysis sales.
  • U.S. segment revenue more than doubled to USD 280,095, reflecting higher Trachealator activity and initial Outflo sales following the launch.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medinotec Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001663577-26-000202), on July 09, 2026, and is solely responsible for the information contained therein.